Literature DB >> 7531612

Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid).

H M Burt1, J K Jackson, S K Bains, R T Liggins, A M Oktaba, A L Arsenault, W L Hunter.   

Abstract

'Large' (30-100 microns) and 'small' (10-30 microns) size range taxol-loaded microspheres composed of a blend of biodegradable poly (d,l-lactic acid) (PLA) polymer and nondegradable ethylene-vinyl acetate (EVA) copolymer were prepared using the solvent evaporation method. Encapsulation efficiencies were between 95-100% for taxol in 50:50 EVA:PLA blend microspheres. Between 10-13% of the total taxol content of the microspheres (0.6% w/v taxol loading) was released in 50 days. Using the chick chorioallantoic membrane (CAM) model, the taxol microspheres released sufficient taxol to produce vascular regression and inhibition of angiogenesis. This taxol-loaded microsphere formulation may have potential for the targeted delivery of taxol to a tumor via arterial chemoembolization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531612     DOI: 10.1016/0304-3835(94)03614-o

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Antitumor effect of the paclitaxel-eluting membrane in a mouse model.

Authors:  Jin-Seok Park; Seok Jeong; Don Haeng Lee; Jin Hee Maeng; In Suh Park; Sangsoo Park
Journal:  Oncol Lett       Date:  2018-07-17       Impact factor: 2.967

2.  A differential scanning calorimetry study of phosphocholines mixed with paclitaxel and its bromoacylated taxanes.

Authors:  S Ali; S Minchey; A Janoff; E Mayhew
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

3.  Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions.

Authors:  John K Jackson; Kevin C Skinner; Laurette Burgess; Tyler Sun; William L Hunter; Helen M Burt
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

4.  Effect of particle size of nanospheres and microspheres on the cellular-association and cytotoxicity of paclitaxel in 4T1 cells.

Authors:  Sinjan De; Donald W Miller; Dennis H Robinson
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

Review 5.  Progress in the development of alternative pharmaceutical formulations of taxanes.

Authors:  B Nuijen; M Bouma; J H Schellens; J H Beijnen
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

Review 6.  The chicken chorioallantoic membrane model in biology, medicine and bioengineering.

Authors:  Patrycja Nowak-Sliwinska; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  Angiogenesis       Date:  2014-08-20       Impact factor: 9.596

Review 7.  Nanotechnology for angiogenesis: opportunities and challenges.

Authors:  Saeid Kargozar; Francesco Baino; Sepideh Hamzehlou; Michael R Hamblin; Masoud Mozafari
Journal:  Chem Soc Rev       Date:  2020-06-15       Impact factor: 54.564

8.  Angiogenesis in head and neck cancer: a review of the literature.

Authors:  Codecà Carla; Ferrari Daris; Bertuzzi Cecilia; Broggio Francesca; Crepaldi Francesca; Foa Paolo
Journal:  J Oncol       Date:  2011-11-10       Impact factor: 4.375

9.  Paclitaxel Induces Apoptosis in AIDS-Related Kaposi's Sarcoma Cells.

Authors:  J Cai; T Zheng; R Masood; D L Smith; D R Hinton; C N Kim; G Fang; K Bhalla; P S Gill
Journal:  Sarcoma       Date:  2000
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.